Elders RC et al. |
Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). |
2009 |
Vet. Immunol. Immunopathol. |
pmid:19185923
|
Booij-Vrieling HE et al. |
Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. |
2009 |
Vet. Immunol. Immunopathol. |
pmid:19556012
|
Gu JH et al. |
Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. |
2009 |
Vet. J. |
pmid:18682334
|
Ito R et al. |
Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma. |
2003 |
Virchows Arch. |
pmid:12838418
|
Gibbons CL et al. |
Osteoclast-like cells in soft tissue leiomyosarcomas. |
2010 |
Virchows Arch. |
pmid:20127110
|
Ito S and Hata T |
Crystal structure of RANK ligand involved in bone metabolism. |
2004 |
Vitam. Horm. |
pmid:15110169
|
Hao C et al. |
Modulation of TRAIL signaling complex. |
2004 |
Vitam. Horm. |
pmid:15110173
|
Ivanov SD et al. |
[Prognosis of efficacy of organ-saving treatment of invasive bladder cancer]. |
2006 |
Vopr Onkol |
pmid:17168368
|
Gajewska J et al. |
[The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease]. |
2005 |
Wiad. Lek. |
pmid:16238129
|
Sobańska I et al. |
[The influence of sex and age on the osteoprotegerin level in the blood]. |
2007 |
Wiad. Lek. |
pmid:17966895
|